HON
70
-9
STX
70
-3
FDX
55
2
CAT
74
-2
SJM
36
-2
ALL
45
2
BIIB
53
-2
APA
46
-2
ORCL
67
2
NAVI
61
3
AVGO
45
3
EMC
91
-5
MCO
77
4
MRK
46
-4
ORLY
66
16
ES
49
2
LB
21
-20
CMA
77
2
PSA
55
-3
T
56
2
HON
70
-9
STX
70
-3
FDX
55
2
CAT
74
-2
SJM
36
-2
ALL
45
2
BIIB
53
-2
APA
46
-2
ORCL
67
2
NAVI
61
3
AVGO
45
3
EMC
91
-5
MCO
77
4
MRK
46
-4
ORLY
66
16
ES
49
2
LB
21
-20
CMA
77
2
PSA
55
-3
T
56
2
Financhill
Back

Aligos Therapeutics Stock Predictions

7 Stocks to Consider Immediately (must-see chart)

See the green days for 7 major stocks right here, free of charge
Buy
51

ALGS
Aligos Therapeutics

Last Price:
$7.56
Seasonality Move:
-13.29%

7 Day Trial

ALL ACCESS PASS

$ 7

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks

Click Here to Download Your FREE Stock Report Now

Aligos Therapeutics Stock Forecast

  • Over the next 52 weeks, Aligos Therapeutics has on average historically fallen by 49.5% based on the past 4 years of stock performance.
  • Aligos Therapeutics has fallen lower in 4 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
  • Is Aligos Therapeutics Stock Undervalued?
    The current Aligos Therapeutics [ALGS] share price is $7.84. The Score for ALGS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Aligos Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Aligos Therapeutics has on average historically fallen by 49.5% based on the past 4 years of stock performance.

Aligos Therapeutics Stock Rating

Buy
51
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics overpriced?

  • Aligos Therapeutics has fallen lower in 4 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%

Aligos Therapeutics Stock Price History

Is ALGS stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
aligos.com

52-Week Data

52-Week High:
46.80
52-Week Low:
3.76

Prediction Charts

Market Cap:
46.2M
Price in USD:
7.84
Volume:
96K
Beta:
2.79

Technical Analysis

SMA50:
6.30
SMA100:
9.23
SMA200:
15.28
52-Wk Change:
-25.78%

Stock Predictions

  • Is Aligos Therapeutics stock public?
    Yes, Aligos Therapeutics is a publicly traded company.
  • What is the Aligos Therapeutics stock quote today?
    The Aligos Therapeutics stock price is 7.84 USD today.
  • How to buy Aligos Therapeutics stock online?
    You can buy Aligos Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-13 7.69 7.71 8.36 7.59
Jun-16 7.90 8.05 8.28 7.78
Jun-17 8.00 7.53 8.06 7.50
Jun-18 7.58 8.37 8.49 7.43
Jun-20 8.50 7.55 8.50 7.55
Jun-23 7.54 7.18 7.84 7.11
Jun-24 7.21 8.24 8.66 7.21
Jun-25 8.18 7.63 8.54 7.42
Jun-26 7.68 7.14 7.68 7.11
Jun-27 7.15 7.21 7.46 6.88
Jun-30 7.29 7.21 7.44 7.00
Jul-1 7.11 7.39 7.42 6.82
Jul-2 7.39 7.31 7.75 7.17
Jul-3 7.39 7.84 8.06 7.25

Aligos Therapeutics Earnings

Aligos Therapeutics Earnings Report: Per Share Aligos Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Aligos Therapeutics Forecast Revenue Growth

Aligos Therapeutics Stock Analysis: Historical quarterly revenues per share for Aligos Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $1.36 per share, a decrease next quarter of $0.07 per share, an increase this year of $3.67 per share, and a decrease next year of $1.69 per share.

* Aligos Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.